Anthem (ANTM) - Get Report was downgraded to hold from buy at Jefferies. $138 price target. Earnings estimates were also cut, given the company's high exchange exposure, Jefferies said.
Briggs & Stratton (BGG) - Get Report was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: BGG.
Chevron (CVX) - Get Report was initiated with an outperform rating at BMO Capital. $120 price target. The company is at an inflection point and can deliver higher-margin growth, BMO said.
DR Horton (DHI) - Get Report was upgraded to buy from neutral at Bank of America/Merrill Lynch. $36 price target. The recent pullback has created a buying opportunity, analysts said.
Intuit (INTU) - Get Report was downgraded to underweight from equal-weight at Morgan Stanley. $105 price target. The company will likely struggle to expand margins in the future, Morgan said.
KLA-Tencor (KLAC) - Get Report was upgraded to outperform from neutral at Credit Suisse. $85 price target. The company should see higher foundry spending and deserves a higher multiple, Credit Suisse.
Liberty Media (LMCA) was upgraded to buy at Citigroup. $32 price target. Formula One purchase is a transformative deal, Citi said.
Open Text (OTEX) - Get Report was upgraded to outperform at BMO Capital. $73 price target. EMC Enterprise purchase should add 17% to 19% to 2018 earnings, BMO said.
Teva Pharmaceuticals (TEVA) - Get Report was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: TEVA.
Under Armour (UA) - Get Report was initiated with a neutral trading at Nomura. $38 price target. The valuation isn't all that compelling, with shares valued at 50x expected 2017 earnings, Nomura said.
USG (USG) was upgraded to outperform at RBC Capital. The valuation is more attractive, based on a $34 price target, RBC said.
This article was written by a staff member of TheStreet.